Discussion on recent updates and changes in patent law that will impact licensing and technology related M&A transactions. In this discussion, experts from Access Advance, McKool Smith and Wiggin & Dana will provide key insights on the specific changes. Additionally, they will be joined by a representative from the US Patent and Trademark Office who will discuss recent developments at the USPTO including IPR statistics and patent eligibility directives.
Target Audience:
- Corporate and university business development/licensing professionals in technology and life sciences
- M&A, licensing and IP attorneys
- Investors in technology and life sciences